Skip to main content
. 2017 Mar 13;8(23):37263–37277. doi: 10.18632/oncotarget.16146

Table 2. Associations between the six SNPs in the XPG gene and cancer risk.

Variables No. of studies No. of cases No. of controls Homozygous Heterozygous Recessive Dominant Allele
OR(95% CI) P het OR(95% CI) P het OR(95% CI) P het OR(95% CI) P het OR(95% CI) P het
rs1047768 T>C CC vs. TT CT vs. TT CC vs. CT/TT CC/CT vs. TT C vs. T
All 22 12833 15186 1.03 (0.95–1.11) 0.010 1.03 (0.97–1.09) 0.192 1.00 (0.93–1.07) 0.171 1.03 (0.98–1.09) 0.038 1.01 (0.98–1.05) 0.012
Ethnicity
 Caucasian 9 5536 7084 1.03 (0.88–1.21) 0.012 1.04 (0.95–1.14) 0.061 1.00 (0.93–1.07) 0.344 1.04 (0.90–1.20) 0.011 1.01 (0.94–1.10) 0.011
 Asian 13 7297 8102 1.03 (0.92–1.16) 0.081 1.02 (0.96–1.10) 0.493 1.00 (0.90–1.11) 0.116 1.03 (0.96–1.10) 0.304 1.02 (0.97–1.07) 0.105
Cancer type
 Lung 3 1176 1959 1.32 (1.06–1.64) 0.175 1.35 (1.10–1.65) 0.278 1.08 (0.92–1.26) 0.360 1.35 (1.12–1.63) 0.172 1.14 (1.02–1.27) 0.059
 Colorectal 3 2715 3627 0.95 (0.63–1.45) 0.006 0.96 (0.86–1.08) 0.480 0.99 (0.70–1.39) 0.012 0.94 (0.78–1.14) 0.133 0.99 (0.91–1.07) 0.020
 Gastric 6 3064 3413 0.88 (0.74–1.05) 0.118 0.98 (0.88–1.09) 0.263 0.88 (0.74–1.05) 0.279 0.97 (0.87–1.07) 0.127 0.93 (0.82–1.04) 0.073
 Others 10 5878 7517 1.04 (0.93–1.15) 0.507 1.05 (0.96–1.14) 0.670 1.01 (0.93–1.10) 0.725 1.05 (0.97–1.14) 0.628 1.03 (0.98–1.08) 0.659
rs2296147 T>C CC vs. TT CT vs. TT CC vs. CT/TT CC/CT vs. TT C vs. T
All 15 11327 12684 1.10 (1.00–1.12) 0.068 0.95 (0.90–1.01) 0.480 1.08 (0.99–1.18) 0.057 0.97 (0.92–1.03) 0.297 1.00 (0.96–1.04) 0.118
 Gastric 5 3699 3890 1.11 (0.76–1.60) 0.026 0.95 (0.86–1.04) 0.945 1.13 (0.78–1.63) 0.025 0.96 (0.88–1.06) 0.697 0.99 (0.91–1.07) 0.197
rs2227869 G>C CC vs. GG GC vs. GG CC vs. GC/GG GC/CC vs. GG C vs. G
All 11 5898 7448 1.67 (0.82–3.41) 0.924 0.90 (0.80–1.02) 0.153 0.98 (0.73–1.32) 0.699 0.92 (0.81–1.03) 0.108 0.93 (0.83–1.04) 0.079
 PB 5 2336 3951 1.08 (0.37–3.10) 0.793 0.80 (0.65–0.99) 0.239 0.89 (0.65–1.21) 0.766 0.81 (0.66–1.00) 0.170 0.84 (0.71–0.99) 0.115
 HB 6 3562 4829 2.46 (0.91–6.67) 0.852 0.96 (0.82–1.11) 0.198 2.48 (0.91–6.74) 0.865 0.98 (0.84–1.13) 0.190 1.00 (0.87–1.15) 0.202
rs2094258 C>T TT vs. CC CT vs. CC TT vs. CT/CC CT/TT vs. CC T vs. C
All 17 9826 10552 1.09 (1.00–1.19) 0.025 1.00 (0.94–1.07) 0.314 1.07 (0.99–1.16) 0.089 1.02 (0.97–1.09) 0.081 1.03 (0.99–1.08) 0.015
 Gastric 7 3812 4177 0.99 (0.86–1.15) 0.083 0.95 (0.86–1.05) 0.734 1.01 (0.89–1.14) 0.119 0.96 (0.88–1.06) 0.409 0.98 (0.92–1.05) 0.133
rs751402 C>T TT vs. CC CT vs. CC TT vs. CT/CC CT/TT vs. CC T vs. C
All 21 10369 11207 1.18 (1.00–1.39) <0.001 1.10 (0.99–1.23) 0.082 1.02 (0.94–1.10) 0.006 1.11 (0.98–1.25) <0.001 1.08 (0.98–1.18) <0.001
 Gastric 10 4664 5150 1.38 (1.12–1.70) 0.020 1.14 (1.05–1.24) 0.936 1.27 (1.06–1.51) 0.053 1.17 (1.08–1.26) 0.437 1.17(1.07–1.27) 0.043
rs873601 G>A AA vs. GG GA vs. GG AA vs. GA/GG GA/AA vs. GG A vs. G
All 14 10873 12535 1.14 (1.06–1.24) 0.193 1.06 (0.99–1.13) 0.904 1.08 (0.99–1.17) 0.035 1.08 (1.02–1.15) 0.841 1.06 (1.02–1.10) 0.234
 Gastric 5 3727 3918 1.18 (1.04–1.34) 0.333 1.04 (0.93–1.16) 0.663 1.16 (1.04–1.28) 0.263 1.08 (0.98–1.20) 0.578 1.09 (1.02–1.16) 0.336